Mo1995 Healthcare Utilization Was an Independent Predictor of Outcome in Colorectal Cancer Patients From Northern Iran

Semnani, Shahryar; Noorafkan, Z.; Aryaie, Mohammad; Sedaghat, Seyed Mehdi; Ghasemi-Kebria, Fatemeh; Roshandel, Gholamreza

doi:10.1016/s0016-5085(15)32604-4

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…More specifically, the present review included studies published between 2000 and 2018. Based on geographical location, 29 studies were from Iran, 28 -56 4 study from Saudi Arabia, 57 -60 3 from Oman, 61 -63 2 from Jordan, 64,65 1 from Libya, 66 1 from Kuwait, 67 1 from Lebanon, 68 1 from Pakistan 69 and 1 was from United Arab Emirates. 70 The characteristics of the studies are illustrated in Table 1.…”

Section: Resultsmentioning

confidence: 99%

Survival Rate of Colorectal Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis

et al. 2020

View full text Add to dashboard Cite

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. Survival rates are among the most important factors in quality control and assessment of treatment protocols. This study was aimed to assess the survival rate of colorectal cancer in Eastern Mediterranean Region Countries. In the present study we comprehensively searched 6 international databases including PubMed/Medline, ProQuest, Scopus, Embase, Web of Knowledge and Google Scholar for published articles until November 2018. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was applied to evaluate the quality of included studies. The heterogeneity of papers was assessed with the Cochran Test and I-Square statistics. Meta-regression test was performed based on publication year, sample size and Human Development Index (HDI) of each study. Among the total of 1023 titles found in the systematic search, 43 studies were eligible to be included in the present meta-analysis. According to the results, the 1-year, 3-year and 5-year survival rate of patients with Colorectal Cancer was 88.07% (95% CI, 83.22-92.92), 70.67% (95% CI, 66.40-74.93) and, 57.26% (95% CI, 50.43-64.10); respectively. Furthermore, Meta-regressions did not show significant correlations between survival rate and year, sample size or Human Development Index. Survival rates, especially the 5-year survival rate in the EMRO were less than European countries and the USA. Documented and comprehensive evidence-based findings of the present meta-analysis can be used to enhance policies and outcomes of different medical areas including prophylaxis, treatment and health related objectives in colorectal cancer.

show abstract